Avenue Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-3.8M | $-3.8M | — | $442.0K |
| FY2022 | $-7.6M | $-7.6M | — | $649.0K |
| FY2023 | $-9.5M | $-9.5M | — | $906.0K |
| FY2024 | $-9.0M | $-9.0M | — | $1.2M |
| FY2025 | $-1.8M | $-1.8M | — | $665.0K |